IBIO

Value Q4, 24Q1, 25Q2, 25Q3, 25 TTM Total revenue 200 K100 K00 300 K Gross profit 200 K100 K00 300 K Operating expenses 5.4 M6.05 M9.45 M8.37 M 29.26 M Selling/general/admin expenses 2.17 M2.5 M5.17 M5.11 M 14.95 M Research & development 3.22 M3.55 M4.28 M3.25 M 14.31 M Operating income -5.2 M-5.95 M-9.45 M-8.37 M -28.96 M Non-Operating Income, Total 35 K231 K452 K635 K 1.35 M Interest expense, net of interest capitalized 44 K36 K41 K22 K 143 K Non-Operating Income, excl. Interest Expenses 35 K231 K452 K635 K 1.35 M Unusual income/expense ———— — Pretax income -5.21 M-5.76 M-9.03 M-7.75 M -27.75 M Equity in earnings ———— — Taxes 0000 0 Non-controlling/minority interest ———— — After tax other income/expense ———— — Net income before discontinued operations -631 K-5.72 M-8.99 M-7.73 M -23.07 M Discontinued operations -4.53 M——— — Net income -5.16 M-5.72 M-8.99 M-7.73 M -27.61 M Dilution adjustment ———— — Preferred dividends ———— — Diluted net income available to common stockholders -5.16 M-5.67 M-8.99 M-7.73 M -27.56 M Basic earnings per share (Basic EPS) -0.32-0.11-0.09-0.06 -0.58 Diluted earnings per share (Diluted EPS) -0.32-0.11-0.09-0.06 -0.58 Average basic shares outstanding 10.5 M52.98 M99.13 M119.6 M — Diluted shares outstanding 10.5 M52.98 M99.13 M119.6 M — EBITDA -4.99 M3.24 M-9.3 M-8.21 M -19.27 M EBIT -5.2 M-5.95 M-9.45 M-8.37 M -28.96 M Cost of revenue ———— — Other cost of goods sold ———— — Depreciation & amortization (cash flow) 209 K9.19 M146 K152 K 9.69 M